StockData
Valneva SE logo

Valneva SE (VALN) stock

VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 17, 2026Score 1/30
$5.34−0.23 (-4.04%)

Close on Nov 18, 2026Market cap $463.35MP/E –Yield –

Valneva net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2021 it was -€61.39M.

Annual net income

PeriodPeriod endValueChange
FY2021Dec 31, 2021-€61.39M–
FY2020Dec 31, 2020-€55.12M–
FY2019Dec 31, 2019-€811.00K–

More Valneva figures

See a number that looks wrong?